Gregory Madison

Gregory Madison

Corporate Officer/Principal presso PROKIDNEY CORP.
59 anni
Health Technology
Health Services
Consumer Services

Profilo

Gregory Paul Madison is currently Director at Phosphate Therapeutics Ltd. since 2021, Trustee at American Kidney Fund, Inc., and Chief Commercial Officer at ProKidney Corp.
starting in 2026.
Former roles include President, Chief Executive Officer & Director at Keryx Biopharmaceuticals, Inc. from 2015 to 2018; President, Chief Executive Officer & Director at Melt Pharmaceuticals, Inc.; Group Chief Executive Officer & Director at Shield Therapeutics Plc from 2021 to 2024; Director at Kidney Care Partners; Vice President & General Manager-Nephrology at Genzyme Corp.
from 2000 to 2012; and Chief Commercial Officer & Executive VP at AMAG Pharmaceuticals, Inc. from 2013 to 2014.
Education includes undergraduate studies at the University of Massachusetts.

Posizioni attive di Gregory Madison

SocietàPosizioneInizio
PROKIDNEY CORP. Corporate Officer/Principal 25/03/2026
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio 18/06/2021

Precedenti posizioni note di Gregory Madison

SocietàPosizioneFine
SHIELD THERAPEUTICS PLC Amministratore Delegato 24/07/2024
KERYX BIOPHARMACEUTICALS Amministratore Delegato 30/04/2018
Direttore/Membro del Consiglio 30/09/2014
AMAG PHARMACEUTICALS, INC. Corporate Officer/Principal 07/02/2014
Corporate Officer/Principal 01/01/2012
Vedi nel dettaglio l'esperienza di Gregory Madison

Formazione di Gregory Madison

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

78

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private10

Health Technology

Health Technology

Consumer Services

Health Services

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Gregory Madison